Two breakthrough Alzheimer’s drugs cost too much and have too little benefit for NHS use, review finds.
Source: US News and Business Report -usnewsandbusinessreport.com- BBC Breaking
Two Alzheimer's drugs that slow the disease will not be made available on the NHS